SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE: KCI) today announced its subsidiary LifeCell has been granted CE Mark approval by the Netherlands-based notified body, KEMA, for its ...

LifeCell (Branchburg, New Jersey), a subsidiary of Kinetic Concepts (KCI; San Antonio) reported that the LifeCell Strattice reconstructive tissue matrix achieved highly favorable one-year outcomes in ...

In the first week of December Acelity pulled its IPO, and now it is clear why. The private equity-owned woundcare group has sold its Lifecell unit to Allergan (AGN) for $2.9bn in cash, allowing ...

LifeCell hasn’t lost any of its ambition. The Branchburg company has gone from building a niche in the hernia market to becoming a dominant player in the breast reconstruction business. And now, ...

Please provide your email address to receive an email when new articles are posted on . Allergan is set to acquire the LifeCell regenerative medicine company from Acelity for $2.9 billion in cash, ...

June 13 (Reuters) - LifeCell Corp. , which provides human tissue for surgical procedures, said it received marketing approval for its soft tissue repair product, Strattice, from the U.S. Food and Drug ...

Biotechnology company LifeCell Corp. (NasdaqGS:LIFC) said Wednesday that it has received clearance from the Food and Drug Administration for its novel soft-tissue repair product ...

It’s been a busy year of tuck-in deals for Allergan since its record-breaking Pfizer merger collapsed in April. And the company is sneaking in one more buyout agreement before 2016 draws to a close.

SAN ANTONIO--(BUSINESS WIRE)--Centaur Guernsey L.P. Inc. (Centaur) announced today the launch of Acelity, effectively rebranding itself and its subsidiaries Kinetic Concepts, Inc. (KCI), LifeCell ...

CHICAGO (Reuters) - Medical device maker Kinetic Concepts Inc said on Monday it would buy tissue repair company LifeCell for $1.7 billion to expand and diversify its product line, sending Kinetic ...

San Antonio medical technology company Acelity LP Inc. announced Tuesday it is selling LifeCell, its regenerative medicine business, to pharmaceutical giant Allergan for $2.9 billion in cash. The sale ...